Benjamin G.
- Country
- France
- Department
- Infectiology
Research Overview
- OPtimisation of antiviral Therapy in Immunocompromised COVID-19 patients: a randomized factorial controlled strategy trial: the OPTICOV Study
- Efficacy of Pembrolizumab in Progressive Multifocal Leukoencephalopathy in Immunocompromised Patients Excluding HIV and Biologic-Induced Immunosuppression
- Efficacy and Safety Evaluation of Pritelivir in Immunocompromised Patients with Acyclovir-Resistant Mucocutaneous Herpes Simplex Virus Infections
Data & Insights
Has run more than one trial at 18 of 146 partner sites.
Specializations
Viral Infections
This investigator specializes in treating severe viral infections, with particular emphasis on managing COVID-19 and herpes simplex virus (HSV) in complex patient populations.
- SARS-CoV-2 infection management
- Antiviral therapy optimization
- Drug-resistant viral infections
The research focus includes innovative therapeutic approaches for viral diseases affecting immunocompromised patients.
Immunocompromised Care
Dedicated to developing treatment strategies for immunocompromised patients who face unique challenges in fighting infections.
- Resistant viral infection management
- Alternative treatment protocols
- Long-term therapeutic strategies
Special attention is given to treating patients who have developed resistance to conventional therapies.
Respiratory Medicine
Expert in treating respiratory tract infections and developing comprehensive treatment approaches for community-acquired pneumonia.
- Acute respiratory infections
- Disease progression monitoring
- Recovery trajectory assessment
The investigator focuses on evaluating multiple intervention strategies for respiratory conditions.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.